Beryl Drugs Limited announced earnings results for the first quarter ended June 30, 2019. For the first quarter, the company announced total revenue was INR 42.330 million compared to INR 41.873 million a year ago. Net income was INR 3.426 million compared to INR 2.024 million a year ago. Basic earnings per share from continuing operations was INR 0.68 compared to INR 0.4 a year ago.